NEOGENOMICS INC
For the period ended Jun 30, 2026. Filed Jul 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 28, 2026
NEO$17.60+4.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit Number | Description of Exhibit | Location |
| 4.1 | Indenture, dated as of June 22, 2026, between NeoGenomics, Inc. and U.S. Bank Trust Company, National Association, as trustee | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 22, 2026. |
| 4.2 | Form of 0.75% Convertible Senior Notes due 2032 (included in Exhibit 4.1) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 22, 2026. |
| 10.1 | Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan, as approved by the Company's stockholders on May 21, 2026 | Incorporated by reference to Annex A of the Company'sProxy Statement on Form DEF 14A as filed with theSEC on April 6, 2026 (File No. 001-35756). |
| 10.2 | Form of Capped Call Transaction Confirmation | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 16, 2026. |
| 31.1 | Certification by Principal Executive Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Provided herewith. |
| 31.2 | Certification by Principal Financial Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Provided herewith. |
| 32.1 | Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Provided herewith. |
| 101.INS | XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) | Provided herewith. |
| 101.SCH | XBRL Taxonomy Extension Schema Document | Provided herewith. |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | Provided herewith. |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | Provided herewith. |
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document | Provided herewith. |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | Provided herewith. |
| 104 | Cover Page Interactive File (formatted as inline XBRL and contained within Exhibit 101) | Provided herewith. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.